Rachel Overman | JPM CBRN Medical

Rachel Overman, , JPM CBRN Medical

Ms. Rachel Overman oversees the development of the antiviral and countermeasures for multi-drug resistance bacteria. She leads multi-functional teams and collaborates with joint service, interagency, international teams of scientists, and acquisition professionals in the development, acquisition, and fielding of U.S. Food and Drug Administration-approved CBRN medical countermeasures.

Appearances:



Festival of Biologics Day 1 @ 11:30

Antibody Roundtables

Title TBA

Festival of Biologics Day 2 @ 12:20

BOT MAB – Phase 1 clinical trial results – Pathway for future monoclonal development with the DoD

last published: 31/Jan/23 09:55 GMT
last published: 31/Jan/23 09:55 GMT

back to speakers